Our Approach

By empowering the human element through a seamless system of interconnected data and alerts more lives can and will be improved and extended.

We have the opportunity to empower and liberate 15 million people with lung disease to improve the quality of their life in the U.S. alone. In addition, we will provide physicians with more detailed and accurate information on a patient’s vital statistics in real-time.

Specifically, there are 6 million people worldwide (1.5 million in the U.S. and Canada) on Long-Term Oxygen Therapy (LTOT).

Our Strategy

We have assembled a team of skilled and motivated experts in the medical, engineering, software, business, marketing, and government relations fields, all focused on dramatically changing the technology and delivery of supplemental oxygen.

Our Goal

Provide high quality, affordable, and portable devices that significantly reduce the burden of supplemental oxygen management for patients and their caregivers.

Meet the Team

With success across a variety of consumer-focused industries, we balance medical expertise with business, marketing, and sales strategy.

Troy Meester

Vice President and CTO

With decades of computer systems design and integration experience, Troy is highly skilled in the areas of hardware and system design, integration, and medical device quality assurance.

Jeff Swigris, DO, MS

Medical Director

With over 23 years of experience in the field of pulmonary medicine and as Lead, Interstitial Lung Disease Program at National Jewish Health in Denver, Colorado, Jeff brings deep medical knowledge specific to lung disease patients to the team. Voted as one of America’s Best Doctors most recently in 2019-2020.